O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+15.41%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.46B
AUM Growth
+$5.46B
(+8.6%)
Cap. Flow
-$50.4M
Cap. Flow
% of AUM
-0.92%
Top 10 Holdings %
Top 10 Hldgs %
41.94%
Holding
129
New
17
Increased
19
Reduced
31
Closed
16
Top Buys
| 1 |
MBX
MBX Biosciences, Inc. Common Stock
MBX
|
$99M |
| 2 |
UnitedHealth
UNH
|
$39.2M |
| 3 |
Sarepta Therapeutics
SRPT
|
$38.5M |
| 4 |
Amgen
AMGN
|
$37.8M |
| 5 |
Universal Health Services
UHS
|
$35.7M |
Top Sells
| 1 |
Janux Therapeutics
JANX
|
$78.2M |
| 2 |
Tenet Healthcare
THC
|
$65M |
| 3 |
Vaxcyte
PCVX
|
$46.7M |
| 4 |
VRNA
Verona Pharma
VRNA
|
$41.4M |
| 5 |
Geron
GERN
|
$37.9M |
Sector Composition
| 1 | Healthcare | 99.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Repare Therapeutics
RPTX
$73.9M
| $11.4M | 0.21% |
3,322,488
| – | – |
|
77
AbCellera Biologics
ABCL
$1.19B
| $10.9M | 0.2% |
4,180,768
| – | – |
|
78
PMV Pharmaceuticals
PMVP
$82.1M
| $9.65M | 0.18% |
6,475,291
| – | – |
|
79
Avalo Therapeutics
AVTX
$139M
| $9.19M | 0.17% |
+967,000
| New | +$9.19M |
|
80
Verastem
VSTM
$585M
| $8.56M | 0.16% |
2,862,448
+1,333,333
| +87% | +$3.99M |
|
81
Lyell Immunopharma
LYEL
$220M
| $8.4M | 0.15% |
6,086,001
-319,097
| -5% | -$440K |
|
82
Oscar Health
OSCR
$4.57B
| $7.46M | 0.14% |
+351,618
| New | +$7.46M |
|
|
BCAX
83
Bicara Therapeutics Inc. Common Stock
BCAX
$655M
| $6.93M | 0.13% |
+271,910
| New | +$6.93M |
|
84
Passage Bio
PASG
$22.7M
| $6.88M | 0.12% |
9,822,876
-301,700
| -3% | -$211K |
|
85
PepGen
PEPG
$39M
| $6.82M | 0.12% |
+797,358
| New | +$6.82M |
|
86
Nkarta
NKTX
$149M
| $6.69M | 0.12% |
1,480,600
+680,600
| +85% | +$3.08M |
|
|
IMA
87
ImageneBio, Inc. Common Stock
IMA
$153M
| $6.12M | 0.11% |
3,539,358
| – | – |
|
88
Amicus Therapeutics
FOLD
$2.42B
| $6.09M | 0.11% |
570,300
| – | – |
|
89
Scholar Rock
SRRK
$3.3B
| $5.95M | 0.11% |
742,300
-332,082
| -31% | -$2.66M |
|
90
Fate Therapeutics
FATE
$115M
| $5.88M | 0.11% |
1,680,580
+325,228
| +24% | +$1.14M |
|
91
InspireMD
NSPR
$101M
| $5.72M | 0.1% |
2,133,405
| – | – |
|
|
LBPH
92
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $5.67M | 0.1% |
+170,000
| New | +$5.67M |
|
93
TELA Bio
TELA
$65.4M
| $5.47M | 0.1% |
2,161,185
-296,357
| -12% | -$750K |
|
94
X4 Pharmaceuticals
XFOR
$70M
| $4.77M | 0.09% |
7,133,515
| – | – |
|
95
Krystal Biotech
KRYS
$4.35B
| $4.28M | 0.08% |
23,500
-6,466
| -22% | -$1.18M |
|
|
ARDT
96
Ardent Health, Inc.
ARDT
$1.83B
| $3.79M | 0.07% |
+206,000
| New | +$3.79M |
|
97
Traws Pharma
TRAW
$11.4M
| $3.56M | 0.06% |
605,531
-439,730
| -42% | +$3.31M |
|
98
Milestone Pharmaceuticals
MIST
$151M
| $3.04M | 0.06% |
2,000,000
| – | – |
|
|
CMMB
99
Chemomab Therapeutics
CMMB
$15.7M
| $2.73M | 0.05% |
1,741,273
-500,000
| -22% | -$785K |
|
100
Instil Bio
TIL
$196M
| $2.27M | 0.04% |
+33,700
| New | +$2.27M |
|